Infection and co-infection patterns of community-acquired pneumonia in patients of different ages in China from 2009 to 2020: a national surveillance study

Abstract

BACKGROUND: Severe community-acquired pneumonia (SCAP) is associated with a substantial number of hospitalisations and deaths worldwide. Infection or co-infection patterns, along with their age dependence and clinical effects are poorly understood. We aimed to explore the causal and epidemiological characteristics by age, to better describe patterns of community-acquired pneumonia (CAP) and their association with severe disease. METHODS: National surveillance of CAP was conducted through a network of hospitals in 30 provinces in China from 2009-20 inclusive. Patients with CAP were included if they had evidence of acute respiratory tract, had evidence of pneumonia by chest radiography, diagnosis of pneumonia within 24 h of hospital admission, and resided in the study catchment area. For the enrolled patients with CAP, nasopharyngeal and oral swabs were taken and tested for eight viral pathogens; and blood, urine, or expectorated sputum was tested for six bacterial pathogens. Clinical outcomes, including SCAP, were investigated with respect to age and patterns of infections or co-infections by performing binary logistic regression and multivariate analysis. FINDINGS: Between January, 2009, and December, 2020, 18 807 patients with CAP (3771 [20·05%] with SCAP) were enrolled. For both children (aged ≤5 years) and older adults (aged >60 years), a higher overall rate of viral and bacterial infections, as well as viral-bacterial co-infections were seen in patients with SCAP than in patients with non-SCAP. For adults (aged 18-60 years), however, only a higher rate of bacterial-bacterial co-infection was observed. The most frequent pathogens associated with SCAP were respiratory syncytial virus (RSV; 21·30%) and Streptococcus pneumoniae (12·61%) among children, and influenza virus (10·94%) and Pseudomonas aeruginosa (15·37%) among older adults. Positive rates of detection of most of the tested pathogens decreased during 2020 compared with the 2009-19 period, except for RSV, P aeruginosa, and Klebsiella pneumoniae. Multivariate analyses showed SCAP was significantly associated with infection with human adenovirus, human rhinovirus, K pneumoniae, or co-infection of RSV and Haemophilus influenzae or RSV and Staphylococcus aureus in children and adolescents (aged <18 years), and significantly associated with infection with P aeruginosa, K pneumoniae, or S pneumoniae, or co-infection with P aeruginosa and K pneumoniae in adults (aged ≥18 years). INTERPRETATION: Both prevalence and infection pattern of respiratory pathogens differed between patients with SCAP and patients with non-SCAP in an age-dependent manner. These findings suggest potential advantages to age-related strategies for vaccine schedules, as well as clinical diagnosis, treatment, and therapy. FUNDING: China Mega-Project on Infectious Disease Prevention and The National Natural Science Funds of China. TRANSLATION: For the Chinese translation of the abstract see Supplementary Materials section.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 28

1. 1.

   American Thoracic Society. Urgent progress needed to end the preventable burden of pneumonia and deaths: the forum of international respiratory societies. 2020. https://www.thoracic.org/about/newsroom/press-releases/journal/2020/urgentprogress-needed-to-end-the-preventable-burden-of-pneumoniaand-deaths-firs.php (accessed March 18, 2023).

   Not in our library

2. 2.
   Promoting the use of social networks in pneumonia · 2020

   Not checked
3. 3.

   Mandell LA. Community-acquired pneumonia: an overview. Postgrad Med 2015; 127: 607–15.

   Not in our library10.1080/00325481.2015.1074030

4. 4.

   Liang L, Moore B, Soni A. National inpatient hospital costs: the most expensive conditions by payer, 2017. In: Healthcare Cost and Utilization Project Statistical Briefs Rockville, MD: US Agency for Healthcare Research and Quality, 2020.

   Not in our library

5. 5.

   Ruuskanen O, Lahti E, Jennings LC, Murdoch DR. Viral pneumonia. Lancet 2011; 377: 1264–75.

   Not in our library10.1016/s0140-6736(10)61459-6

6. 6.

   Li Z, Chen Q, Feng L, Active case finding with case management: the key to tackling the COVID-19 pandemic. Lancet 2020; 396: 63–70.

   Not in our library10.1016/s0140-6736(20)31278-2

7. 7.
   The role of co-infections and secondary infections in patients with COVID-19 · 2021

   No notice
8. 8.

   Murray CJL, Ikuta KS, Sharara F, Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 2022; 399: 629–55.

   Not in our library10.1016/s0140-6736(21)02724-0

9. 9.
   Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019 · 2022

   No notice
10. 10.
    Etiological and epidemiological features of acute respiratory infections in China · 2021

    No notice
11. 11.

    WHO. Guidelines for the management of common childhood illnesses. 2nd edition. 2013. https://www.ncbi.nlm.nih.gov/books/NBK154448/#ch4.s8 (acessed Feb 15, 2022).

    Not in our library

12. 12.

    Mandell LA, Wunderink RG, Anzueto A, Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44 (Suppl 2): S27–72.

    Not in our library10.1086/511159

13. 13.

    Li MF, Ren LL, Yu HJ. Pathogen surveillance and detection techniques: febrile respiratory syndrome. Guangzhou: Sun YatSen University Press, 2017 (in Chinese).

    Not in our library

14. 14.

    DeJonge P, Martin ET, Hayashi M, Johnson S, Hashikawa AN. Communicable disease outbreaks in Michigan child care centers compared with state and regional epidemics, 2014–2017. Am J Public Health 2019; 109: 1707–10.

    Not in our library10.2105/ajph.2019.305355

15. 15.

    Prendergast AJ, Klenerman P, Goulder PJ. The impact of differential antiviral immunity in children and adults. Nat Rev Immunol 2012; 12: 636–48.

    Not in our library10.1038/nri3277

16. 16.

    Prigge AD, Ma R, Coates BM, Singer BD, Ridge KM. Age-dependent differences in T-Cell responses to influenza A virus. Am J Respir Cell Mol Biol 2020; 63: 415–23.

    Not in our library10.1165/rcmb.2020-0169tr

17. 17.
    Viral Interference between Respiratory Viruses · 2022

    No notice
18. 18.

    DaPalma T, Doonan BP, Trager NM, Kasman LM. A systematic approach to virus-virus interactions. Virus Res 2010; 149: 1–9.

    Not in our library10.1016/j.virusres.2010.01.002

19. 19.
    Viral and Bacterial Interactions in the Upper Respiratory Tract · 2013

    No notice
20. 20.

    Bakaletz LO. Viral-bacterial co-infections in the respiratory tract. Curr Opin Microbiol 2017; 35: 30–5.

    Not in our library10.1016/j.mib.2016.11.003

21. 21.

    Cawcutt K, Kalil AC. Pneumonia with bacterial and viral coinfection. Curr Opin Crit Care 2017; 23: 385–90.

    Not in our library10.1097/mcc.0000000000000435

22. 22.

    Nair H, Simões EA, Rudan I, Global and regional burden of hospital admissions for severe acute lower respiratory infections in young children in 2010: a systematic analysis. Lancet 2013; 381: 1380–90.

    Not in our library10.1016/s0140-6736(12)61901-1

23. 23.

    Ursin RL, Klein SL. Sex differences in respiratory viral pathogenesis and treatments. Annu Rev Virol 2021; 8: 393–414.

    Not in our library10.1146/annurev-virology-091919-092720

24. 24.

    Tsolia MN, Psarras S, Bossios A, Etiology of community-acquired pneumonia in hospitalized school-age children: evidence for high prevalence of viral infections. Clin Infect Dis 2004; 39: 681–6.

    Not in our library10.1086/422996

25. 25.

    Metersky ML, Masterton RG, Lode H, File TM Jr, Babinchak T. Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenza. Int J Infect Dis 2012; 16: e321–31

    Not in our library10.1016/j.ijid.2012.01.003

26. 26.

    Clementi N, Ghosh S, De Santis M, Viral respiratory pathogens and lung injury. Clin Microbiol Rev 2021; 34: e00103–20..

    Not in our library10.1128/cmr.00103-20

27. 27.

    Xu B, Wang J, Li Z, Seasonal association between viral causes of hospitalised acute lower respiratory infections and meteorological factors in China: a retrospective study. Lancet Planet Health 2021; 5: e154–63.

    Not in our library10.1016/s2542-5196(20)30297-7

28. 28.

    du Prel JB, Puppe W, Gröndahl B, Are meteorological parameters associated with acute respiratory tract infections? Clin Infect Dis 2009; 49: 861–68.

    Not in our library10.1086/605435

Cited by papers we hold 1

• Application of targeted metagenomic next-generation sequencing in pneumonia patients · 2025
  Not checked

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.